Skip to main content
Log in

Simultaneous occurrence of prostate cancer and IgE myeloma, a rare hematolymphoid malignancy

  • CASE REPORT
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

An unusual case of the simultaneous occurrence of prostate cancer and IgE myeloma is reported. A 74-year-old man with urinary disturbance and elevated serum prostate-specific antigen level, of 7.4 ng/ml, showed Bence-Jones protein in the urine. Immunoelectrophoresis of the serum showed elevation of IgE kappa monoclonal protein. Radical prostatectomy was performed as a curative therapy for T1c, Gleason 3-2 prostate cancer. The patient has remained free of progression of both the myeloma and the prostate cancer for 26 months after the initial diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: March 23, 2000 / Accepted: July 19, 2000

About this article

Cite this article

Igarashi, T., Takane, Y., Takahashi, H. et al. Simultaneous occurrence of prostate cancer and IgE myeloma, a rare hematolymphoid malignancy. Int J Clin Oncol 5, 334–336 (2000). https://doi.org/10.1007/PL00012059

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00012059

Navigation